Shares of Regulus Therapeutics (NASDAQ:RGLS) spiked on Thursday after the microRNA-focused drug developer announced additional topline data from a Phase 1b trial for its lead asset, farabursen, ...

In a dispute arising from a federal power infrastructure project, the Eighth Circuit Court of Appeals ruled in favor of Liberty Mutual Insurance Company, finding that the insurer was not liable under ...